Shinya Unai, MD, provides an update on reoperation volumes and outcomes for the Department of Thoracic and Cardiovascular Surgery at Cleveland Clinic.Learn more about the Department of Thoracic and Cardiovascular Surgery.

Marc Gillinov, MD, provides an update on volumes and outcomes for the Department of Thoracic and Cardiovascular Surgery at Cleveland Clinic.Learn more about the Department of Thoracic and Cardiovascular Surgery.Looking to refer ...

Luke Laffin, MD, shares the findings from a late breaker he presented at ACC 2025. Lorundrostat is an investigational drug found to significantly lower 24-hour blood pressure among patients with uncontrolled and resistant hypertension. ...

Steven Nissen, MD, shares the findings from a late breaker he presented at ACC 2025.  Lepodisiran is a small interfering RNA that targets lipoprotein(a) levels, lowering a patient's risk for atherosclerosis and aortic stenosis.

The OPTION clinical trial compared left atrial appendage closure to continued oral anticoagulation in patients at risk of stroke after undergoing atrial fibrillation (AFib) ablation. Oussama Wazni, MD and Mohamed Kanj, MD discuss the findings o...

Patrick Vargo, MD provides an update on surgery volumes and outcomes from the Aorta Center. Learn more about the Aorta Center. Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri....

Faisal Bakaeen, MD provides an update on the state of coronary artery surgery. Learn more about the Coronary Artery Bypass Surgery Center.

Lars Svensson, MD, PhD, Chief of Cleveland Clinic's Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute, and Marc Gillinov, MD, Chair of Thoracic and Cardiovascular Surgery, continue their discussion with a detailed overview ...

Join Lars Svensson, MD, PhD, Chief of Cleveland Clinic's Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute, and Marc Gillinov, MD, Chair of Thoracic and Cardiovascular Surgery, as they discuss the unparalleled expertise a...

Haytham Elgharably, MD, discusses new trends and contemporary data from studies on the management of endocarditis. Learn more about the Endocarditis Center. Looking to refer a patient? Please reach out to our Physician...

Robotically assisted heart surgery provides an alternative to a sternotomy that offers many benefits to the patient. Marc Gillinov, MD, and Tarek Malas, MD, discuss these benefits and considerations for a successful outcome.Looking to r...

Amar Krishnaswamy, MD, provides an update on Cleveland Clinic's Section of Interventional Cardiology.Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET), toll-free 800.223.2273, ...

Cardiac rehabilitation is a program that combines exercise, diet and education to help people with heart conditions. Erik Van Iterson, PhD, MS, MA, explains the many benefits of cardiac rehab, including an improvement in quality of life for pat...

Heart disease is the leading cause of mortality in women in the United States and around the world. Vikas Sunder, MD, a cardiologist in the Department of Preventive Cardiology, discusses what clinicians should do to address this. Learn ...

Grant Reed, MD, discusses the considerations and risks of TAVR in bicuspid aortic valves.Learn more about Tall Rounds online. http://2207941.mediaspace.kal...

Cardiotoxicity from radiation therapy can develop within days or months after radiation, but it often develops years later. Milind Desai, MD, MBA, and Shinya Unai, MD, discuss considerations for managing patients with radiation heart disease.

Amar Krishnaswamy, MD, provides the TAVR perspective on SAVR in patients with small annulus, including outcomes of TAVR vs SAVR.  Learn more about Tall Rounds online.

Diets for heart health are not one size fits all.  Julia Zumpano, RD. discusses several different heart health diets and how to help your patient determine the best option for them. Learn more about Preventive Cardiology & Reha...

Leonardo Rodriguez, MD, discusses patient prosthesis mismatch, imaging and clinical considerations for the aortic valve. Learn more about Tall Rounds online. ...

The study found that people with any type of COVID-19 infection were twice as likely to have a major cardiac event, such as heart attack, stroke or even death, for up to three years after diagnosis. Stanley Hazen, MD, PhD summarizes the finding...

Eric Roselli, MD, provides an overview, a complex cardiac sarcoma case is presented by Holliann Willekes, MD, followed by an update on imaging modalities from Patrick Collier, MD, PhD, and a perspective on pathology from Marc Halushka, MD, PhD....

Lee Kirksey, MD, moderates a panel discussion on diversity in medicine with Miriam Jacob, MD, Milind Desai, MD, James Carter, MD, and Quinn Capers, MD, Visiting Professor from Howard University.

A Cleveland Clinic-led trial found that a minimally-invasive procedure – left atrial appendage closure (LAAC) – resulted in significantly less bleeding in patients undergoing a catheter ablation to treat atrial fibrillation, compared to oral an...

Mavacamten is the first and only FDA-approved cardiac myosin inhibitor to treat obstructive hypertrophic cardiomyopathy (HCM).  An important factor to the success of the VALOR HCM trial was the participation of specialized cardiac sonograp...

Clinicians should consider statin therapy for primary prevention. Vikas Sunder, MD, a cardiologist in Preventive Cardiology, reviews indicators and considerations for statin initiation as well as barriers to adherence.Learn more about t...